{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:41:41Z","timestamp":1767706901916},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:00:00Z","timestamp":1179100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-244x-7-18","type":"journal-article","created":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T06:13:26Z","timestamp":1179209606000},"source":"Crossref","is-referenced-by-count":29,"title":["Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review"],"prefix":"10.1186","volume":"7","author":[{"given":"Norio","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshi A","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,14]]},"reference":[{"issue":"1","key":"205_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","volume":"51","author":"RC Kessler","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994, 51 (1): 8-19.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"205_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00127-002-0542-y","volume":"37","author":"P Carlbring","year":"2002","unstructured":"Carlbring P, Gustafsson H, Ekselius L, Andersson G: 12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population. Soc Psychiatry Psychiatr Epidemiol. 2002, 37 (5): 207-211. 10.1007\/s00127-002-0542-y.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"6","key":"205_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Walters EE: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005, 62 (6): 617-627. 10.1001\/archpsyc.62.6.617.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"205_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1176\/ajp.149.6.778","volume":"149","author":"AT Beck","year":"1992","unstructured":"Beck AT, Sokol L, Clark DA, Berchick R, Wright F: A crossover study of focused cognitive therapy for panic disorder. Am J Psychiatry. 1992, 149 (6): 778-783.","journal-title":"Am J Psychiatry"},{"issue":"5 Suppl","key":"205_CR5","first-page":"1","volume":"155","author":"American Psychiatric Association","year":"1998","unstructured":"American Psychiatric Association: Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. Am J Psychiatry. 1998, 155 (5 Suppl ): 1-34.","journal-title":"Am J Psychiatry"},{"key":"205_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1192\/bjp.188.4.305","volume":"188","author":"TA Furukawa","year":"2006","unstructured":"Furukawa TA, Watanabe N, Churchill R: Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry. 2006, 188: 305-312. 10.1192\/bjp.188.4.305.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"205_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1037\/0033-3204.30.1.125","volume":"30","author":"WC Sanderson","year":"1993","unstructured":"Sanderson WC, Wetzler S: Observations on the cognitive behavioral treatment of panic disorder: impact of benzodiazepines. Psychotherapy. 1993, 30 (1): 125-132.","journal-title":"Psychotherapy"},{"issue":"3","key":"205_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF02193090","volume":"245","author":"B Bandelow","year":"1995","unstructured":"Bandelow B, Sievert K, Rothemeyer M, Hajak G, Ruther E: What treatments do patients with panic disorder and agoraphobia get?. Eur Arch Psychiatry Clin Neurosci. 1995, 245 (3): 165-171. 10.1007\/BF02193090.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"205_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-0447.1991.tb03097.x","volume":"365","author":"S Andersch","year":"1991","unstructured":"Andersch S, Rosenberg NK, Kullingsjo H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergard M, Rasmussen S, et al: Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl. 1991, 365: 18-27.","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"6 Suppl 2","key":"205_CR10","doi-asserted-by":"publisher","first-page":"12S","DOI":"10.1097\/00004714-199812001-00004","volume":"18","author":"K Rickels","year":"1998","unstructured":"Rickels K, Schweizer E: Panic disorder: long-term pharmacotherapy and discontinuation. J Clin Psychopharmacol. 1998, 18 (6 Suppl 2): 12S-18S. 10.1097\/00004714-199812001-00004.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"205_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","volume":"18","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF: Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs. 2004, 18 (1): 37-48. 10.2165\/00023210-200418010-00004.","journal-title":"CNS Drugs"},{"issue":"3","key":"205_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/1047-2797(94)00112-7","volume":"5","author":"CI Neutel","year":"1995","unstructured":"Neutel CI: Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol. 1995, 5 (3): 239-244. 10.1016\/1047-2797(94)00112-7.","journal-title":"Ann Epidemiol"},{"issue":"4","key":"205_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ageing\/25.4.273","volume":"25","author":"CI Neutel","year":"1996","unstructured":"Neutel CI, Hirdes JP, Maxwell CJ, Patten SB: New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996, 25 (4): 273-278. 10.1093\/ageing\/25.4.273.","journal-title":"Age Ageing"},{"key":"205_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-0447.1998.tb05973.x","volume":"393","author":"E Schweizer","year":"1998","unstructured":"Schweizer E, Rickels K: Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl. 1998, 393: 95-101.","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"5","key":"205_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/archpsyc.1988.01800290043006","volume":"45","author":"JC Pecknold","year":"1988","unstructured":"Pecknold JC, Swinson RP, Kuch K, Lewis CP: Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects. Arch Gen Psychiatry. 1988, 45 (5): 429-436.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"205_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1037\/0022-006X.72.4.625","volume":"72","author":"ME Addis","year":"2004","unstructured":"Addis ME, Hatgis C, Krasnow AD, Jacob K, Bourne L, Mansfield A: Effectiveness of cognitive \u2013 behavioral treatment for panic disorder versus treatment as usual in a managed care setting. J Consult Clin Psychol. 2004, 72 (4): 625-635. 10.1037\/0022-006X.72.4.625.","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"205_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1037\/0022-006X.67.4.583","volume":"67","author":"DM Clark","year":"1999","unstructured":"Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M: Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol. 1999, 67 (4): 583-589. 10.1037\/0022-006X.67.4.583.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"205_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1037\/0022-006X.71.6.1068","volume":"71","author":"JA Kenardy","year":"2003","unstructured":"Kenardy JA, Dow MG, Johnston DW, Newman MG, Thomson A, Taylor CB: A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial. J Consult Clin Psychol. 2003, 71 (6): 1068-1075. 10.1037\/0022-006X.71.6.1068.","journal-title":"J Consult Clin Psychol"},{"key":"205_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1192\/bjp.178.4.331","volume":"178","author":"LM Ito","year":"2001","unstructured":"Ito LM, de Araujo LA, Tess VL, de Barros-Neto TP, Asbahr FR, Marks I: Self-exposure therapy for panic disorder with agoraphobia: randomised controlled study of external v. interoceptive self-exposure. Br J Psychiatry. 2001, 178: 331-336. 10.1192\/bjp.178.4.331.","journal-title":"Br J Psychiatry"},{"key":"205_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1192\/bjp.162.6.776","volume":"162","author":"IM Marks","year":"1993","unstructured":"Marks IM, Swinson RP, Basoglu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S, et al: Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry. 1993, 162: 776-787.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"205_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0005-7967(93)90026-Q","volume":"31","author":"MJ Telch","year":"1993","unstructured":"Telch MJ, Lucas JA, Schmidt NB, Hanna HH, LaNae Jaimez T, Lucas RA: Group cognitive-behavioral treatment of panic disorder. Behav Res Ther. 1993, 31 (3): 279-287. 10.1016\/0005-7967(93)90026-Q.","journal-title":"Behav Res Ther"},{"issue":"5","key":"205_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1037\/0022-006X.63.5.823","volume":"63","author":"MJ Telch","year":"1995","unstructured":"Telch MJ, Schmidt NB, Jaimez TL, Jacquin KM, Harrington PJ: Impact of cognitive-behavioral treatment on quality of life in panic disorder patients. J Consult Clin Psychol. 1995, 63 (5): 823-830. 10.1037\/0022-006X.63.5.823.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"205_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0005-7967(95)00063-1","volume":"34","author":"SL Williams","year":"1996","unstructured":"Williams SL, Falbo J: Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability. Behav Res Ther. 1996, 34 (3): 253-264. 10.1016\/0005-7967(95)00063-1.","journal-title":"Behav Res Ther"},{"issue":"1","key":"205_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.psychres.2003.11.001","volume":"125","author":"V Starcevic","year":"2004","unstructured":"Starcevic V, Linden M, Uhlenhuth EH, Kolar D, Latas M: Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices. Psychiatry Res. 2004, 125 (1): 41-52. 10.1016\/j.psychres.2003.11.001.","journal-title":"Psychiatry Res"},{"issue":"6","key":"205_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1176\/ajp.154.6.773","volume":"154","author":"DA Spiegel","year":"1997","unstructured":"Spiegel DA, Bruce TJ: Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials. Am J Psychiatry. 1997, 154 (6): 773-781.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"205_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0272-7358(97)00084-6","volume":"18","author":"HA Westra","year":"1998","unstructured":"Westra HA, Stewart SH: Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?. Clin Psychol Rev. 1998, 18 (3): 307-340. 10.1016\/S0272-7358(97)00084-6.","journal-title":"Clin Psychol Rev"},{"key":"205_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1192\/bjp.156.2.163","volume":"156","author":"J Wardle","year":"1990","unstructured":"Wardle J: Behaviour therapy and benzodiazepines: allies or antagonists?. Br J Psychiatry. 1990, 156: 163-168.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"205_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1037\/0022-006X.63.5.754","volume":"63","author":"TA Brown","year":"1995","unstructured":"Brown TA, Barlow DH: Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol. 1995, 63 (5): 754-765. 10.1037\/0022-006X.63.5.754.","journal-title":"J Consult Clin Psychol"},{"key":"205_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0005-7894(96)80028-1","volume":"27","author":"MW Otto","year":"1996","unstructured":"Otto MW, Pollack MH, Sabatino SA: Maintenance of remission following cognitive behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment. Behav Ther. 1996, 27: 473-482. 10.1016\/S0005-7894(96)80028-1.","journal-title":"Behav Ther"},{"issue":"2","key":"205_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00005053-199602000-00015","volume":"184","author":"AJ van Balkom","year":"1996","unstructured":"van Balkom AJ, de Beurs E, Koele P, Lange A, can Dyck R: Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia. J Nerv Ment Dis. 1996, 184 (2): 133-135. 10.1097\/00005053-199602000-00015.","journal-title":"J Nerv Ment Dis"},{"issue":"3","key":"205_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0887-6185(02)00091-9","volume":"16","author":"HA Westra","year":"2002","unstructured":"Westra HA, Stewart SH, Conrad BE: Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia. J Anxiety Disord. 2002, 16 (3): 233-246. 10.1016\/S0887-6185(02)00091-9.","journal-title":"J Anxiety Disord"},{"key":"205_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0005-7894(05)80282-5","volume":"25","author":"MT Hegel","year":"1994","unstructured":"Hegel MT, Ravaris CL, Ahles TA: Combined cognitive behavioral and time-limited alprazolam treatment of panic disorder. Behav Ther. 1994, 25: 183-195. 10.1016\/S0005-7894(05)80282-5.","journal-title":"Behav Ther"},{"issue":"9","key":"205_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0005-7967(97)00038-7","volume":"35","author":"TP Oei","year":"1997","unstructured":"Oei TP, Llamas M, Evans L: Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?. Behav Res Ther. 1997, 35 (9): 851-857. 10.1016\/S0005-7967(97)00038-7.","journal-title":"Behav Res Ther"},{"issue":"5","key":"205_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1192\/bjp.164.5.647","volume":"164","author":"M Basoglu","year":"1994","unstructured":"Basoglu M, Marks IM, Kilic C, Swinson RP, Noshirvani H, Kuch K, O'Sullivan G: Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. Br J Psychiatry. 1994, 164 (5): 647-652.","journal-title":"Br J Psychiatry"},{"key":"205_CR35","unstructured":"Higgins JPT, Green S, editors: Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [Updated May 2005]. The Cochrane Library. 2005, Chichester, UK: John Wiley & Sons, Ltd, 4.2.5, 3"},{"issue":"1","key":"205_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","volume":"20","author":"TA Furukawa","year":"2005","unstructured":"Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N: Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol. 2005, 20 (1): 49-52. 10.1097\/00004850-200501000-00010.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"205_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/ije\/31.1.72","volume":"31","author":"TA Furukawa","year":"2002","unstructured":"Furukawa TA, Guyatt GH, Griffith LE: Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol. 2002, 31 (1): 72-76. 10.1093\/ije\/31.1.72.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"205_CR38","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med. 2002, 21 (11): 1539-1558. 10.1002\/sim.1186.","journal-title":"Stat Med"},{"issue":"1","key":"205_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1017\/S0033291700007510","volume":"6","author":"J Hafner","year":"1976","unstructured":"Hafner J, Marks I: Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. Psychol Med. 1976, 6 (1): 71-88.","journal-title":"Psychol Med"},{"issue":"1","key":"205_CR40","first-page":"42","volume":"14","author":"JC Lopez Alonso","year":"2000","unstructured":"Lopez Alonso JC, Gomez-Jarabo G: A model of therapeutic action in panic disorders. The European journal of psychiatry. 2000, 14 (1): 42-51.","journal-title":"The European journal of psychiatry"},{"issue":"2","key":"205_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0005-7967(94)90113-9","volume":"32","author":"J Wardle","year":"1994","unstructured":"Wardle J, Hayward P, Higgitt A, Stabl M, Blizard R, Gray J: Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia. Behav Res Ther. 1994, 32 (2): 203-215. 10.1016\/0005-7967(94)90113-9.","journal-title":"Behav Res Ther"},{"issue":"5","key":"205_CR42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1192\/bjp.164.5.652","volume":"164","author":"M Basoglu","year":"1994","unstructured":"Basoglu M, Marks IM, Kilic C, Brewin CR, Swinson RP: Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. Br J Psychiatry. 1994, 164 (5): 652-659.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"205_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0165-0327(94)90040-X","volume":"30","author":"M Basoglu","year":"1994","unstructured":"Basoglu M, Marks IM, Swinson RP, Noshirvani H, O'Sullivan G, Kuch K: Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. J Affect Disord. 1994, 30 (2): 123-132. 10.1016\/0165-0327(94)90040-X.","journal-title":"J Affect Disord"},{"issue":"8","key":"205_CR44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1001\/archpsyc.1997.01830200078011","volume":"54","author":"M Basoglu","year":"1997","unstructured":"Basoglu M, Marks I, Livanou M, Swinson R: Double-blindness procedures, rater blindness, and ratings of outcome. Observations from a controlled trial. Arch Gen Psychiatry. 1997, 54 (8): 744-748.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"205_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0165-0327(95)00053-4","volume":"35","author":"AJ Bond","year":"1995","unstructured":"Bond AJ, Curran HV, Bruce MS, O'Sullivan G, Shine P: Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam. J Affect Disord. 1995, 35 (3): 117-123. 10.1016\/0165-0327(95)00053-4.","journal-title":"J Affect Disord"},{"issue":"4","key":"205_CR46","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1017\/S0033291700029056","volume":"24","author":"HV Curran","year":"1994","unstructured":"Curran HV, Bond A, O'Sullivan G, Bruce M, Marks I, Lelliot P, Shine P, Lader M: Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of agoraphobia with panic disorder. Psychol Med. 1994, 24 (4): 969-976.","journal-title":"Psychol Med"},{"issue":"1","key":"205_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/S003329179800734X","volume":"29","author":"C Kilic","year":"1999","unstructured":"Kilic C, Curran HV, Noshirvani H, Marks IM, Basoglu M: Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia\/panic patients. Psychol Med. 1999, 29 (1): 225-231. 10.1017\/S003329179800734X.","journal-title":"Psychol Med"},{"key":"205_CR48","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1192\/bjp.163.6.835a","volume":"163","author":"DF Klein","year":"1993","unstructured":"Klein DF: Panic disorder with agoraphobia. Br J Psychiatry. 1993, 163: 835-837.","journal-title":"Br J Psychiatry"},{"key":"205_CR49","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1192\/bjp.162.6.795","volume":"162","author":"IM Marks","year":"1993","unstructured":"Marks IM, Basoglu M, Noshirvani H, Greist J, Swinson RP, O'Sullivan G: Drug treatment of panic disorder. Further comment. Br J Psychiatry. 1993, 162: 795-796.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"205_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1192\/bjp.165.1.79","volume":"165","author":"GH O'Sullivan","year":"1994","unstructured":"O'Sullivan GH, Noshirvani H, Basoglu M, Marks IM, Swinson R, Kuch K, Kirby M: Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder. Br J Psychiatry. 1994, 165 (2): 79-86.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"205_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/026988119601000204","volume":"10","author":"GH O'Sullivan","year":"1996","unstructured":"O'Sullivan GH, Swinson R, Kuch K, Marks IM, Basoglu M, Noshirvani H: Alprazolam withdrawal symptoms in agoraphobia with panic disorder: observations from a controlled Anglo-Canadian study. J Psychopharmacol. 1996, 10 (2): 101-109. 10.1177\/026988119601000204.","journal-title":"J Psychopharmacol"},{"key":"205_CR52","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1192\/bjp.162.6.788","volume":"162","author":"DA Spiegel","year":"1993","unstructured":"Spiegel DA, Roth M, Weissman M, Lavori P, Gorman J, Rush J, Ballenger J: Comment on the London\/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia. Br J Psychiatry. 1993, 162: 788-789. discussion 790\u2013784","journal-title":"Br J Psychiatry"},{"issue":"4","key":"205_CR53","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/BF02246023","volume":"125","author":"P Hayward","year":"1996","unstructured":"Hayward P, Wardle J, Higgitt A, Gray J: Changes in \"withdrawal symptoms\" following discontinuation of low-dose diazepam. Psychopharmacology (Berl). 1996, 125 (4): 392-397. 10.1007\/BF02246023.","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"205_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0005-7967(85)90140-8","volume":"23","author":"DL Chambless","year":"1985","unstructured":"Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C: The Mobility Inventory for Agoraphobia. Behav Res Ther. 1985, 23 (1): 35-44. 10.1016\/0005-7967(85)90140-8.","journal-title":"Behav Res Ther"},{"issue":"2","key":"205_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/anxi.3070010204","volume":"1","author":"R Pohl","year":"1994","unstructured":"Pohl R, Balon R, Berchou R, Lycaki H: Lactate-induced anxiety after imipramine and diazepam treatment. Anxiety. 1994, 1 (2): 54-63.","journal-title":"Anxiety"},{"issue":"9","key":"205_CR56","first-page":"458","volume":"47","author":"DL Dunner","year":"1986","unstructured":"Dunner DL, Ishiki D, Avery DH, Wilson LG, Hyde TS: Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J Clin Psychiatry. 1986, 47 (9): 458-460.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"205_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/archpsyc.1984.01790140077009","volume":"41","author":"R Noyes Jr","year":"1984","unstructured":"Noyes R, Anderson DJ, Clancy J, Crowe RR, Slymen DJ, Ghoneim MM, Hinrichs JV: Diazepam and propranolol in panic disorder and agoraphobia. Arch Gen Psychiatry. 1984, 41 (3): 287-292.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"205_CR58","first-page":"349","volume":"57","author":"R Noyes Jr","year":"1996","unstructured":"Noyes R, Burrows GD, Reich JH, Judd FK, Garvey MJ, Norman TR, Cook BL, Marriott P: Diazepam versus alprazolam for the treatment of panic disorder. J Clin Psychiatry. 1996, 57 (8): 349-355.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"205_CR59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0005-7967(82)90140-1","volume":"20","author":"DL Chambless","year":"1982","unstructured":"Chambless DL, Foa EB, Groves GA, Goldstein AJ: Exposure and communications training in the treatment of agoraphobia. Behav Res Ther. 1982, 20 (3): 219-231. 10.1016\/0005-7967(82)90140-1.","journal-title":"Behav Res Ther"},{"issue":"3","key":"205_CR60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00464571","volume":"77","author":"G Chouinard","year":"1982","unstructured":"Chouinard G, Annable L, Fontaine R, Solyom L: Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Psychopharmacology (Berl). 1982, 77 (3): 229-233. 10.1007\/BF00464571.","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"205_CR61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1891\/0889-8391.5.3.199","volume":"5","author":"MG Craske","year":"1991","unstructured":"Craske MG: Models and treatment of panic: behavioural therapy of panic. Journal of cognitive psychotherapy. 1991, 5 (3): 199-214.","journal-title":"Journal of cognitive psychotherapy"},{"key":"205_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1017\/S1352465800010481","volume":"21","author":"E Echeburua","year":"1993","unstructured":"Echeburua E, De Corral P, Garcia Bajos E, Borda M: Interactions between self-exposure and alprazolam in the treatment of agoraphobia without current panic: an exploratory study. Behavioural and Cognitive Psychotherapy. 1993, 21: 219-38.","journal-title":"Behavioural and Cognitive Psychotherapy"},{"issue":"575","key":"205_CR63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1192\/bjp.123.4.463","volume":"123","author":"D Johnston","year":"1973","unstructured":"Johnston D, Gath D: Arousal levels and attribution effects in diazepam-assisted flooding. Br J Psychiatry. 1973, 123 (575): 463-466.","journal-title":"Br J Psychiatry"},{"issue":"10","key":"205_CR64","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","volume":"150","author":"MW Otto","year":"1993","unstructured":"Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF: Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993, 150 (10): 1485-1490.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"205_CR65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0887-6185(95)00003-7","volume":"9","author":"WT Riley","year":"1995","unstructured":"Riley WT, McCormick M, Simon EM, Stack K, Pushkin Y, Overstreet MM: Effects of alprazolam dose on the induction and habituation processes during behavioral panic induction treatment. J Anxiety Disord. 1995, 9 (3): 217-227. 10.1016\/0887-6185(95)00003-7.","journal-title":"J Anxiety Disord"},{"issue":"6","key":"205_CR66","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1176\/ajp.151.6.876","volume":"151","author":"DA Spiegel","year":"1994","unstructured":"Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A: Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?. Am J Psychiatry. 1994, 151 (6): 876-881.","journal-title":"Am J Psychiatry"},{"key":"205_CR67","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0005-7916(78)90032-0","volume":"9","author":"WE Whitehead","year":"1978","unstructured":"Whitehead WE, Robinson A, Blackwell B, Stutz RM: Flooding treatment of phobias: does chronic diazepam increase effectiveness?. J Behav Ther Exp Psychiatry. 1978, 9: 219-225. 10.1016\/0005-7916(78)90032-0.","journal-title":"J Behav Ther Exp Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-7-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-7-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-7-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-7-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T06:08:28Z","timestamp":1548223708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-7-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,14]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-7-18","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,14]]},"article-number":"18"}}